Assessment of efficacy of curcumin & honey in cough for lung cancer patients
Phase 2
- Conditions
- Health Condition 1: C341- Malignant neoplasm of upper lobe,bronchus or lung
- Registration Number
- CTRI/2023/06/054088
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient who are diagnosed of lung cancer and having cough
-Cough severity will be more than or equal to 40 mm as per cough VAS
-Patient who are on NACT or Adjuvant treatment
-Patient with ECOG score is 0 to 2
-Willing to participate in study
-Who follow the Marathi or Hindi or English language
Exclusion Criteria
-Cancer Patients other than lung metastasis
-Patients with diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the efficacy of curcumin & honey consumption in cough on patients with lung cancer at Day22 <br/ ><br>Timepoint: 3 months
- Secondary Outcome Measures
Name Time Method -To assess the incidence & degree of cough on patients with lung cancer. <br/ ><br>-To define the association between clinical data and efficacy of curcumin and honey in cough on patients <br/ ><br>with lung cancer. <br/ ><br>Timepoint: 3 months